1165 related articles for article (PubMed ID: 35392086)
41. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
[TBL] [Abstract][Full Text] [Related]
42. Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer.
Yang Y; Zhou L; Gou X; Wu G; Zheng Y; Liu M; Chen Z; Wang Y; Ji R; Guo Q; Zhou Y
Math Biosci Eng; 2022 Jan; 19(1):595-611. PubMed ID: 34903003
[TBL] [Abstract][Full Text] [Related]
43. A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.
Ren W; Zhang J; Li W; Li Z; Hu S; Suo J; Ying X
Med Sci Monit; 2016 Oct; 22():3647-3657. PubMed ID: 27727196
[TBL] [Abstract][Full Text] [Related]
44. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
45. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
Front Genet; 2022; 13():989719. PubMed ID: 36212154
[No Abstract] [Full Text] [Related]
46. Construction of prognostic signature of patients with oral squamous cell carcinoma based on pyroptosis-related long non-coding RNAs.
Xin Y; Zhang J; Jiang Q; Qiu J
Front Surg; 2022; 9():935765. PubMed ID: 36211292
[TBL] [Abstract][Full Text] [Related]
47. Construction and validation of a glycolysis-related lncRNA signature for prognosis prediction in Stomach Adenocarcinoma.
Liao T; Lu Y; Li W; Wang K; Zhang Y; Luo Z; Ju Y; Ouyang M
Front Genet; 2022; 13():794621. PubMed ID: 36313430
[No Abstract] [Full Text] [Related]
48. A novel pyroptosis-related gene signature predicts the prognosis of glioma through immune infiltration.
Zhang M; Cheng Y; Xue Z; Sun Q; Zhang J
BMC Cancer; 2021 Dec; 21(1):1311. PubMed ID: 34876094
[TBL] [Abstract][Full Text] [Related]
49. Prognosis and Tumour Immune Microenvironment of Patients With Hepatocellular Carcinoma by a Novel Pyroptosis-Related lncRNA Signature.
Zhang Z; Shang J; Hu B; Shi H; Cao Y; Li J; Jiao T; Zhang W; Lu S
Front Immunol; 2022; 13():836576. PubMed ID: 35812396
[TBL] [Abstract][Full Text] [Related]
50. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
Wang Y; Zhang X; Dai X; He D
Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
[No Abstract] [Full Text] [Related]
51. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
52. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
Liu Z; Liu H; Wang Y; Li Z
BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
Front Genet; 2022; 13():760514. PubMed ID: 35273635
[No Abstract] [Full Text] [Related]
54. Comprehensive Analysis of the Correlation Between Pyroptosis-Related LncRNAs and Tumor Microenvironment, Prognosis, and Immune Infiltration in Hepatocellular Carcinoma.
Qu G; Wang D; Xu W; Guo W
Front Genet; 2022; 13():867627. PubMed ID: 35559014
[No Abstract] [Full Text] [Related]
55. An Immunity-Associated lncRNA Signature for Predicting Prognosis in Gastric Adenocarcinoma.
Zhao X; Wu P; Liu D; Li C; Xue L; Liu Z; Zhu M; Yang J; Chen Z; Li Y; She Y
J Healthc Eng; 2022; 2022():3035073. PubMed ID: 35509706
[TBL] [Abstract][Full Text] [Related]
56. Integrating multiple machine learning algorithms for prognostic prediction of gastric cancer based on immune-related lncRNAs.
Li G; Huo D; Guo N; Li Y; Ma H; Liu L; Xie H; Zhang D; Qu B; Chen X
Front Genet; 2023; 14():1106724. PubMed ID: 37082204
[No Abstract] [Full Text] [Related]
57. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
Front Immunol; 2021; 12():719175. PubMed ID: 34603293
[TBL] [Abstract][Full Text] [Related]
58. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
59. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
